Clinical TrialsSearch results
Number of results: 2545
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A Randomized Phase II Clinical Trial of Tailored CPT-11 + S-1 vs S-1 in Patients with Advanced or Recurrent Gastric Carcinoma as the First Line Chemotherapy
- Advanced or recurrent gastric cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2005-08-31
Other
- Randomized phase III study of 5-FU continuous infusion (5-FUci) versus CPT-11 plus CDDP (CP) versus S-1 alone (S-1) in advanced gastric cancer (JCOG9912)
- advanced or recurrent gastric cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-16
Other
- Randomized phase III study of TS-1 alone versus TS-1 plus Lentinan(LNT) in advanced or recurrent gastric cancer (AGC)
- Advanced or recurrent gastric cancer (AGC)
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2007-01-20
Other
- ONO-7119-01:Phase I study of ONO-7119 alone and in combination with ONO-4538 in patients with solid tumors
- advanced or recurrent solid tumor
- Hirashima Yoshinori
- 2021-10-12
Other
- NCCH2006/MK010 trial
- advanced or recurrent solid tumor with fibroblast growth factor receptor (FGFR) gene alteration
- Takahashi Masamichi
- 2021-04-20
Recruiting
- Phase I trial sponsored by Rakuten Medical K.K.
- Advanced or recurrent solid tumors with one or more hepatic metastasis
- Okuda Daisuke
- 2023-03-21
Other
- Phase I Study of Gemcitabine-Combined WT1 Peptide Vaccine Treatment for Patients with Advanced Pancreas or Biliary Duct Cancer
- Advanced pancreatic cancer or biliary duct cancer
- Department of Clinical Trial Coordination and Developmental Therapeutics National Cancer Center Hospital
- 2007-11-28
Recruiting
- JCOG1905: A randomized controlled phase III trial on continued or paused PD-1 pathway blockade for patients with advanced renal cell carcinoma
- advanced renal cell carcinoma
- MATSUMOTO Takashi
- 2020-07-20
Recruiting
- Phase I, Two-Part, Multi-Center, First-in-Human Study of DS-6000a in Subjects with Advanced Renal Cell Carcinoma and Ovarian Tumors
- Advanced Renal Cell Carcinoma and Ovarian Tumors
- Inoguchi Akihiro
- 2022-05-19
Other
- JCOG1802: A randomized phase II trial of 2nd line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib
- Advanced soft tissue sarcoma
- TANAKA Kazuhiro
- 2019-12-05